Anlon Healthcare IPO Details: Price, Dates & Financials

Pre-issue shareholding: 39,851,500 shares. Post-issue shareholding: 53,151,500 shares.

Anlon Healthcare IPO is a Fresh Capital issue. Issue type: Bookbuilding IPO. Face value is ₹10.

The UPI mandate for Anlon Healthcare IPO needs to be accepted by 29 Aug 2025. Approve the mandate request in your UPI app before the deadline, otherwise your bid may be rejected.

The Red Herring Prospectus (RHP) of Anlon Healthcare IPO is available on the website of the lead manager and the stock exchange (NSE & BSE) — see the lead manager links on the main page.

The DRHP is the initial offer document filed for regulatory review, while the RHP includes updated disclosures, final issue details, and the price band (when announced). Comparing both documents helps investors identify changes in the Anlon Healthcare IPO's financial information, risks, and offer terms before investing in the Anlon Healthcare IPO. Reviewing both documents provides a clearer understanding of the Anlon Healthcare IPO before making an investment decision.

The DRHP and RHP of the Anlon Healthcare IPO disclose potential risks related to the company's business, financial performance, legal matters, and industry conditions. Reviewing these documents helps investors identify potential concerns about the Anlon Healthcare IPO, evaluate the Anlon Healthcare IPO's risk factors, and make a more informed decision before investing in the Anlon Healthcare IPO.